Membranoproliferative Glomerulonephritis - 6 Studies Found
Active, not recruiting |
: Eculizumab in Primary MPGN : Membranoproliferative Glomerulonephritis : 2014-03-17 : Drug: Eculizumab Other Name: Soliris |
Not yet recruiting |
: Daratumumab in Treatment of PGNIMD and C3 GN : Membranoproliferative Glomerulonephritis : 2017-03-20 : Drug: Daratumumab Open-label Other Name: Darzalex |
Completed |
: Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis : Glomerulonephritis, Membranoproliferative : 2006-01-10 : Drug: Rituximab The Rituximab dose is 1000 mg (1 gm) given as an IV infusion every two weeks for 2 doses |
Completed |
: Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy :
|
Not yet recruiting |
: A Proof-of-Mechanism Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients With C3G or IC-MPGN :
|